Other potential biomarkers for DKD, based on adult studies, are urinary neutrophil gelatinase–associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), N-acetyl-β-d-glucosaminidase (NAG), and liver fatty acid–binding protein (LFABP). Here, LCN2 is linked to diabetic kidney disease.